The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 23, 2021
Mayne Pharma is pleased to announce that the FDA has approved LEXETTE® (halobetasol propionate) foam, 0.05% for use in adolescents. LEXETTE, a super ...
read more
Thursday, September 23, 2021
Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the generic version of Pfizer...
read more
Thursday, September 23, 2021
AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialization of the proprietary self-...
read more
Thursday, September 23, 2021
The FDA approved ruxolitinib (Jakafi, Incyte Corp.) for chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic ...
read more
Wednesday, September 22, 2021
Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children...
read more
Wednesday, September 22, 2021
Pfizer and BioNTech that the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the FDA grant ...
read more
Wednesday, September 22, 2021
Samsung Bioepis and Biogen announced that the FDA has approved BYOOVIZ™ (ranibizumab-nuna), a biosimilar referencing LUCENTIS® (ranibizumab)i, for the...
read more
Tuesday, September 21, 2021
The FDA is announcing the availability of guidance for industry entitled, “Questions and Answers on Quality-Related Controlled Correspondence.” The ...
read more
Tuesday, September 21, 2021
The U.S. FDA in partnership with the European Medicines Agency (EMA), launched a pilot program to provide parallel scientific advice (PSA) to ...
read more
Tuesday, September 21, 2021
AbbVie announced that it has submitted applications seeking approval for upadacitinib (15 mg and 30 mg (maintenance dose) and 45 mg (induction dose)) ...
read more
Tuesday, September 21, 2021
HOOKIPA Pharma Inc, a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced it has ...
read more
Monday, September 20, 2021
The FDA revised the emergency use authorization (EUA) for bamlanivimab and etesevimab, administered together, to include emergency use as post-...
read more
Thursday, September 16, 2021
Theravance Biopharma, Inc. announced strategic actions to focus on leveraging its expertise in developing and commercializing respiratory therapeutics...
read more
Thursday, September 16, 2021
BeiGene announced that BRUKINSA® (zanubrutinib) has received accelerated approval from the FDA for the treatment of adult patients with relapsed or ...
read more
Wednesday, September 15, 2021
The Novo Nordisk Foundation and the Broad Institute of MIT and Harvard announced the launch of the Novo Nordisk Foundation Center for Genomic ...
read more